Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
ADA 2024: CGMS results of deescalation with iGlarLixi vs continuing MDI

ADA 2024: CGMS results of deescalation with iGlarLixi vs continuing MDI

Interview with Dr. Peter Novodvorsky

ADA 2024: iGlarLixi RWE according to BMI

ADA 2024: iGlarLixi RWE according to BMI

Interview with Dr. Kis János Tibor 

ADA 2024: Insulin therapy deintensification with iGlarLixi vs continuing MDI

ADA 2024: Insulin therapy deintensification with iGlarLixi vs continuing MDI

Interview with Prof. Dr. Martin Haluzík

Γνωρίστε το Insulin Campus της Sanofi

Γνωρίστε το Insulin Campus της Sanofi

Rhino Rounds International - Moving forward in CRSwNP

Rhino Rounds International - Moving forward in CRSwNP

Manifestaciones óseas de pacientes con enfermedad de Gaucher tipo 1

Manifestaciones óseas de pacientes con enfermedad de Gaucher tipo 1

Las manifestaciones esqueléticas que afectan a los pacientes con enfermedad de Gaucher tipo 1 son: el dolor óseo, la osteonecrosis, la osteopenia, las fracturas y la deformidad esquelética (giba).

Opleidingsmateriaal Beyfortus (nirsevimab) voor de preventie van RSV bij zuigelingen

Opleidingsmateriaal Beyfortus (nirsevimab) voor de preventie van RSV bij zuigelingen

Nirsevimab (Beyfortus) reimbursement conditions and forms

Nirsevimab (Beyfortus) reimbursement conditions and forms

Speaker Academy training module – RSV immunization approaches

Speaker Academy training module – RSV immunization approaches

Influenza HD – Summary of evidence – Executive deck

Influenza HD – Summary of evidence – Executive deck

Speaker Academy training module – The burden of RSV

Speaker Academy training module – The burden of RSV

Scheda informativa per i medici che prescrivono MULTAQ®

Scheda informativa per i medici che prescrivono MULTAQ®